...
gh-img

Guardant Health Inc, Common Stock

GH

NSQ

$32.36

-$2.48

(-7.12%)

1D
Industry: Health Care Providers & Services Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$4.30B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.91M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.11
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$15.81 L
$38.53 H
$32.36

About Guardant Health Inc, Common Stock

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California. more

Industry: Health Care Providers & ServicesSector: Health Care

Returns

Time FrameGHSectorS&P500
1-Week Return-9.25%-2.06%-0.55%
1-Month Return11.74%-1.92%2.72%
3-Month Return29.03%-10.4%7.66%
6-Month Return8.08%-4.6%10.15%
1-Year Return18.88%4.06%27.53%
3-Year Return-67.53%1.94%32.31%
5-Year Return-59.28%36.48%89.2%
10-Year Return0.5%97.46%194.59%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue214.38M286.73M373.65M449.54M563.95M[{"date":"2019-12-31","value":38.01,"profit":true},{"date":"2020-12-31","value":50.84,"profit":true},{"date":"2021-12-31","value":66.26,"profit":true},{"date":"2022-12-31","value":79.71,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue70.72M92.53M122.91M156.32M227.05M[{"date":"2019-12-31","value":31.15,"profit":true},{"date":"2020-12-31","value":40.75,"profit":true},{"date":"2021-12-31","value":54.13,"profit":true},{"date":"2022-12-31","value":68.85,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit143.66M194.19M250.74M293.21M336.90M[{"date":"2019-12-31","value":42.64,"profit":true},{"date":"2020-12-31","value":57.64,"profit":true},{"date":"2021-12-31","value":74.43,"profit":true},{"date":"2022-12-31","value":87.03,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin67.01%67.73%67.11%65.23%59.74%[{"date":"2019-12-31","value":98.94,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":99.08,"profit":true},{"date":"2022-12-31","value":96.31,"profit":true},{"date":"2023-12-31","value":88.2,"profit":true}]
Operating Expenses226.03M449.14M661.74M837.59M901.62M[{"date":"2019-12-31","value":25.07,"profit":true},{"date":"2020-12-31","value":49.82,"profit":true},{"date":"2021-12-31","value":73.39,"profit":true},{"date":"2022-12-31","value":92.9,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(82.37M)(254.95M)(411.00M)(544.38M)(564.73M)[{"date":"2019-12-31","value":-8237100000,"profit":false},{"date":"2020-12-31","value":-25495000000,"profit":false},{"date":"2021-12-31","value":-41100100000,"profit":false},{"date":"2022-12-31","value":-54437800000,"profit":false},{"date":"2023-12-31","value":-56472500000,"profit":false}]
Total Non-Operating Income/Expense25.21M14.45M27.88M(105.58M)118.75M[{"date":"2019-12-31","value":21.23,"profit":true},{"date":"2020-12-31","value":12.17,"profit":true},{"date":"2021-12-31","value":23.48,"profit":true},{"date":"2022-12-31","value":-88.91,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(69.72M)(245.90M)(384.47M)(653.45M)(478.76M)[{"date":"2019-12-31","value":-6972300000,"profit":false},{"date":"2020-12-31","value":-24590400000,"profit":false},{"date":"2021-12-31","value":-38447000000,"profit":false},{"date":"2022-12-31","value":-65344900000,"profit":false},{"date":"2023-12-31","value":-47876400000,"profit":false}]
Income Taxes(1.87M)379.00K300.00K1.14M685.00K[{"date":"2019-12-31","value":-164.35,"profit":false},{"date":"2020-12-31","value":33.27,"profit":true},{"date":"2021-12-31","value":26.34,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":60.14,"profit":true}]
Income After Taxes(67.85M)(246.28M)(384.77M)(654.59M)(479.45M)[{"date":"2019-12-31","value":-6785100000,"profit":false},{"date":"2020-12-31","value":-24628300000,"profit":false},{"date":"2021-12-31","value":-38477000000,"profit":false},{"date":"2022-12-31","value":-65458800000,"profit":false},{"date":"2023-12-31","value":-47944900000,"profit":false}]
Income From Continuous Operations(67.85M)(246.28M)(384.77M)(654.59M)(479.45M)[{"date":"2019-12-31","value":-6785100000,"profit":false},{"date":"2020-12-31","value":-24628300000,"profit":false},{"date":"2021-12-31","value":-38477000000,"profit":false},{"date":"2022-12-31","value":-65458800000,"profit":false},{"date":"2023-12-31","value":-47944900000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(67.85M)(246.28M)(384.77M)(654.59M)(479.45M)[{"date":"2019-12-31","value":-6785100000,"profit":false},{"date":"2020-12-31","value":-24628300000,"profit":false},{"date":"2021-12-31","value":-38477000000,"profit":false},{"date":"2022-12-31","value":-65458800000,"profit":false},{"date":"2023-12-31","value":-47944900000,"profit":false}]
EPS (Diluted)(0.84)(2.58)(4.00)(5.25)(3.55)[{"date":"2019-12-31","value":-84,"profit":false},{"date":"2020-12-31","value":-258,"profit":false},{"date":"2021-12-31","value":-400,"profit":false},{"date":"2022-12-31","value":-525,"profit":false},{"date":"2023-12-31","value":-355,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

GH
Cash Ratio 5.06
Current Ratio 6.22
Quick Ratio 5.85

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

GH
ROA (LTM) -16.08%
ROE (LTM) -609.28%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

GH
Debt Ratio Lower is generally better. Negative is bad. 1.04
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.04

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

GH
Trailing PE NM
Forward PE NM
P/S (TTM) 5.78
P/B 55.67
Price/FCF NM
EV/R 6.71
EV/Ebitda NM

FAQs

What is Guardant Health Inc share price today?

Guardant Health Inc (GH) share price today is $32.36

Can Indians buy Guardant Health Inc shares?

Yes, Indians can buy shares of Guardant Health Inc (GH) on Vested. To buy Guardant Health Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in GH stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Guardant Health Inc be purchased?

Yes, you can purchase fractional shares of Guardant Health Inc (GH) via the Vested app. You can start investing in Guardant Health Inc (GH) with a minimum investment of $1.

How to invest in Guardant Health Inc shares from India?

You can invest in shares of Guardant Health Inc (GH) via Vested in three simple steps:

  • Click on Sign Up or Invest in GH stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Guardant Health Inc shares
What is Guardant Health Inc 52-week high and low stock price?

The 52-week high price of Guardant Health Inc (GH) is $38.53. The 52-week low price of Guardant Health Inc (GH) is $15.81.

What is Guardant Health Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Guardant Health Inc (GH) is

What is Guardant Health Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Guardant Health Inc (GH) is 55.67

What is Guardant Health Inc dividend yield?

The dividend yield of Guardant Health Inc (GH) is 0.00%

What is the Market Cap of Guardant Health Inc?

The market capitalization of Guardant Health Inc (GH) is $4.30B

What is Guardant Health Inc’s stock symbol?

The stock symbol (or ticker) of Guardant Health Inc is GH

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top